Gyre Therapeutics (GYRE) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,460.00 |
| Dec 31, 2025 | 6,918.00 |
| Sep 30, 2025 | 6,062.00 |
| Jun 30, 2025 | 5,547.00 |
| Mar 31, 2025 | 5,984.00 |
| Dec 31, 2024 | 10,170.00 |
| Sep 30, 2024 | -725.00 |
| Jun 30, 2024 | -1,380.00 |
| Mar 31, 2024 | -2,838.00 |
| Dec 31, 2023 | -12,841.00 |
| Sep 30, 2023 | 4,167.00 |
| Jun 30, 2023 | -10,693.00 |
| Mar 31, 2023 | 9,516.00 |
| Dec 31, 2022 | 9,751.00 |
| Sep 30, 2022 | 9,757.00 |
| Jun 30, 2022 | 6,883.00 |
| Mar 31, 2022 | -12,140.00 |
| Dec 31, 2021 | -7,683.00 |
| Sep 30, 2021 | -2,987.00 |
| Jun 30, 2021 | -1,135.00 |
| Mar 31, 2021 | -3,291.00 |
| Dec 31, 2020 | -2,679.00 |
| Sep 30, 2020 | -3,018.00 |
| Jun 30, 2020 | -3,950.00 |
| Mar 31, 2020 | -3,334.00 |
| Dec 31, 2019 | -7,330.00 |
| Sep 30, 2019 | -4,676.00 |
| Jun 30, 2019 | -2,498.00 |
| Mar 31, 2019 | -623.00 |
| Dec 31, 2018 | 632.00 |
| Sep 30, 2018 | 1,200.00 |
| Jun 30, 2018 | 925.00 |
| Mar 31, 2018 | -1,663.00 |
| Dec 31, 2017 | -7,295.00 |
| Sep 30, 2017 | -7,612.00 |
| Jun 30, 2017 | -8,242.00 |
| Mar 31, 2017 | -9,887.00 |
| Dec 31, 2016 | -8,409.00 |
| Sep 30, 2016 | -8,818.00 |